Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

125%

5 of 4 completed trials have results

Key Signals

1 recruiting5 with results

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06083519Not ApplicableRecruiting

Assessment of a Novel Sound-based Treatment for Managing Distress Related to Tinnitus

Role: collaborator

NCT05054816Not ApplicableCompleted

Speech Locator In-car Performance Evaluation

Role: collaborator

NCT04882709Not ApplicableTerminated

Compression Headphone Study

Role: collaborator

NCT05197803Not ApplicableCompleted

Clinical Study of Released Unitron RIC and BTE Hearing Aid Models

Role: collaborator

NCT05377359Not ApplicableCompleted

Lab Evaluation of Novel Hearing Aid Coupling Method

Role: collaborator

NCT04882787Not ApplicableCompleted

Validation of Novel BTE and SP Hearing Aid Models

Role: collaborator

All 6 trials loaded